ExodusPoint Capital Management »

Nurix Therapeutics shares owned by ExodusPoint Capital Management

Quarter-by-quarter ownership of Nurix Therapeutics (NRIX) shares owned by ExodusPoint Capital Management from 13F filings

Historical chart of ExodusPoint Capital Management investment in Nurix Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Nurix Therapeutics held by ExodusPoint Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Nurix Therapeutics by ExodusPoint Capital Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $778k 35k 22.48
2024-03-31 $2.4M 166k 14.70
2023-09-30 $394k 50k 7.86
2023-06-30 $417k 42k 10.00
2022-09-30 $338k 26k 13.02
2022-03-31 $211k 15k 14.03
2021-09-30 $322k 11k 29.96

More positions owned by ExodusPoint Capital Management

Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
NVIDIA Corporation (NVDA)
Microsoft Corporation Put Option (MSFT)
Ishares Tr Russell 2000 Etf Call Option (IWM)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
Ishares Tr 20 Yr Tr Bd Etf Call Option (TLT)
Johnson & Johnson Put Option (JNJ)
Ishares Tr Iboxx Hi Yd Etf Call Option (HYG)
NiSource (NI)
CMS Energy Corporation (CMS)
PPL Corporation (PPL)
Tesla Motors Put Option (TSLA)
Mondelez Intl Cl A (MDLZ)
Becton, Dickinson and (BDX)
Exelon Corporation (EXC)

View all positions for ExodusPoint Capital Management

Top funds holding Nurix Therapeutics

BlackRock
Redmile Group
Baker Bros. Advisors
T. Rowe Price Associates
T. Rowe Price Investment Management
ARK Investment Management
Pictet Asset Management Holding SA
Commodore Capital
Citadel Advisors
Geode Capital Management
Driehaus Capital Management
Affinity Asset Advisors
Deutsche Bank Aktiengesellschaft
Daniel D. Thurber
Samlyn Capital

View all funds holding Nurix Therapeutics